Valuation Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

Real-time Estimate Tradegate Other stock markets 01:29:59 10/07/2026 am IST			5-day change	1st Jan Change
56.12 ^EUR	-1.19%		-1.22%	-10.27%

13/05	Spanish stocks - Factors to watch on May 13	RE
09/05	Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,138	1,925	3,213	3,220	3,248	2,869	-	-
Change	-	-53.49%	66.93%	0.22%	0.87%	-11.65%	-	-
Enterprise Value (EV) ¹	4,112	1,872	3,251	3,305	3,272	2,842	2,784	2,668
Change	-	-54.48%	73.7%	1.65%	-1%	-13.15%	-2.04%	-4.15%
P/E	26.7x	9.67x	18.8x	23.6x	23.1x	21.5x	16.2x	13.2x
PBR	8.59x	3.71x	5.94x	5.63x	4.89x	3.8x	3.25x	2.79x
PEG	-	0.3x	-1.3x	-1.4x	7.71x	-4.39x	0.5x	0.6x
Capitalization / Revenue	6.38x	2.35x	3.87x	4.22x	4.37x	3.71x	3.19x	2.91x
EV / Revenue	6.34x	2.29x	3.92x	4.33x	4.4x	3.67x	3.1x	2.7x
EV / EBITDA	20.3x	6.72x	13.3x	15.9x	15.1x	13.9x	10.5x	8.42x
EV / EBIT	22.7x	7.32x	14.8x	18.4x	17.6x	16.6x	12.1x	9.51x
EV / FCF	37.9x	10.1x	54.3x	43.5x	27.4x	30.1x	22.4x	16.2x
FCF Yield	2.64%	9.95%	1.84%	2.3%	3.65%	3.33%	4.47%	6.18%
Dividend per Share ²	0.9556	1.294	1.104	0.9351	0.9594	0.9732	1.12	1.359
Rate of return	1.29%	3.59%	1.83%	1.49%	1.51%	1.73%	2%	2.42%
EPS ²	2.76	3.73	3.2	2.67	2.75	2.615	3.469	4.238
Distribution rate	34.6%	34.7%	34.5%	35%	34.9%	37.2%	32.3%	32.1%
Net sales ¹	648.7	817.7	829.5	763.7	743.5	774	898.2	986.9
EBITDA ¹	202.9	278.7	244.5	207.4	216.2	204.2	264	316.7
EBIT ¹	181.5	255.8	220.1	179.4	185.8	171.6	229.3	280.5
Net income ¹	153.1	199.7	170.3	136.9	140.4	133	177.6	217
Net Debt ¹	-25.87	-52.78	38.6	85.1	23.84	-27.87	-85.9	-201.4
Reference price ²	73.80	36.06	60.20	62.95	63.50	56.10	56.10	56.10
Nbr of stocks (in thousands)	56,069	53,375	53,370	51,149	51,149	51,149	-	-
Announcement Date	23/02/22	21/02/23	27/02/24	25/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.46x	12.91x	26.29x	0.56%	1,08400Cr
JOHNSON & JOHNSON	28.11x	6.45x	17.52x	2.03%	63TCr
ABBVIE INC.	30.45x	7.46x	15.28x	2.72%	45TCr
ROCHE HOLDING AG	17.81x	4.43x	10.97x	2.99%	33TCr
ASTRAZENECA PLC	23.78x	4.98x	13.89x	1.75%	30TCr
NOVARTIS AG	21.66x	5.57x	13.46x	2.83%	28TCr
NOVO NORDISK A/S	14.26x	5.31x	10.9x	3.51%	22TCr
AMGEN INC.	24.07x	6.37x	11.22x	2.74%	20TCr
GILEAD SCIENCES, INC.	-48.15x	5.84x	32.48x	2.39%	17TCr
Average	16.38x	6.59x	16.89x	2.39%	40.67TCr
Weighted average by Cap.	24.24x	8.02x	18.60x	1.95%